Y Cheng1, J Xu, J Guo, Y Jin, X Wang, Q Zhang, L Liu. 1. Biological Therapy Unit and Surgical Department, Second Clinical Hospital, Jilin University, Changchun, 130034, China.
Abstract
PURPOSE: There is an urgent need to identify biomarkers for early diagnosis and prognosis of esophageal cancer. The present study was undertaken to test whether circulating autoantibodies to ATP-binding cassette C3 (ABCC3) transporter could serve as a biomarker for the malignant tumor. METHODS: An enzyme-linked immunosorbent assay approach was developed in-house to test circulating autoantibodies to ABCC3 in 114 patients with esophageal squamous cell carcinoma (ESCC) and 226 healthy subjects well matched in age and smoking history. RESULTS: Mann-Whitney U test showed that the IgA antibody levels were significantly higher in patients with ESCC than control subjects (Z = -4.226, P < 0.001) while the IgG antibody levels were not significantly different between the two groups (Z = -1.072, P = 0.284). The sensitivity against >95 % specificity was 13.2 % for the IgA assay with an inter-assay deviation of 13.0 and 7.9 % for the IgG assay with an inter-assay deviation of 9.4 %. CONCLUSIONS: This work suggests that circulating IgA autoantibody to ABCC3 may be a potential biomarker for ESCC, which could be used for early diagnosis and prognosis of the malignant tumor.
PURPOSE: There is an urgent need to identify biomarkers for early diagnosis and prognosis of esophageal cancer. The present study was undertaken to test whether circulating autoantibodies to ATP-binding cassette C3 (ABCC3) transporter could serve as a biomarker for the malignant tumor. METHODS: An enzyme-linked immunosorbent assay approach was developed in-house to test circulating autoantibodies to ABCC3 in 114 patients with esophageal squamous cell carcinoma (ESCC) and 226 healthy subjects well matched in age and smoking history. RESULTS: Mann-Whitney U test showed that the IgA antibody levels were significantly higher in patients with ESCC than control subjects (Z = -4.226, P < 0.001) while the IgG antibody levels were not significantly different between the two groups (Z = -1.072, P = 0.284). The sensitivity against >95 % specificity was 13.2 % for the IgA assay with an inter-assay deviation of 13.0 and 7.9 % for the IgG assay with an inter-assay deviation of 9.4 %. CONCLUSIONS: This work suggests that circulating IgA autoantibody to ABCC3 may be a potential biomarker for ESCC, which could be used for early diagnosis and prognosis of the malignant tumor.
Authors: Y T Chen; M J Scanlan; U Sahin; O Türeci; A O Gure; S Tsang; B Williamson; E Stockert; M Pfreundschuh; L J Old Journal: Proc Natl Acad Sci U S A Date: 1997-03-04 Impact factor: 11.205
Authors: Laura Partanen; Johan Staaf; Minna Tanner; Vilppu J Tuominen; Åke Borg; Jorma Isola Journal: Genes Chromosomes Cancer Date: 2012-05-14 Impact factor: 5.006
Authors: C Chapman; A Murray; J Chakrabarti; A Thorpe; C Woolston; U Sahin; A Barnes; J Robertson Journal: Ann Oncol Date: 2007-03-07 Impact factor: 32.976
Authors: N E Annels; G R Simpson; M Denyer; S E McGrath; G Falgari; E Killick; R Eeles; J Stebbing; D Pchejetski; R Cutress; N Murray; A Michael; H Pandha Journal: Clin Exp Immunol Date: 2014-08 Impact factor: 4.330